Next Generation Pharmaceutical Manufacturing Europe will take place from 6th - 8th December in Barcelona, Spain and will provide leading executives with an ideal framework for new business relationships to flourish.The summit has elected more than 50 of the most well respected executives in the European pharmaceutical industry. Speakers will include Bo Hilligsøe, VP Finished Goods Production, H.Lundbeck; Bart Moors, Director of Business & Project Development Life Science at Siemens; Philippe Gerwill, Head Global IT Purchasing, Novartis; and many more. Sponsors include leading companies such as Pegasus, Lodestone, and Corden Pharma amongst others.The summit will see senior level executives from drug manufacturing companies across Europe meet to discuss key objectives for the industry.Fabrizio Borin, Head of Production at Lundbeck Pharmaceuticals Italy, said of June's Pharma Manufacturing event, "It was a relaxed environment in which you have the chance to talk together, exchange ideas, and network. It was a very, very good experience."As well as comprehensive workshops, the summit involves panel discussions offering executives moderated, peer-led discussions on major industry issues. One-to-one meetings will give delegates the chance to meet with business analysts and analyst partners to discuss pressing issues for the industry.A total of 16 workshops will cover sustainable business strategy, best practices for optimising manufacturing processes, virtualisation, maximising supply chain efficiency, and much more.Gareth Jones, Summit Director at GDS International - the global business event company behind NG Pharmaceutical Manufacturing US - says, "Our high caliber of speakers and exciting content, combined with fantastic opportunities for networking, give our delegates and sponsors real value for money and return on their investment and ensures that NG Pharma Manufacturing stands out against other events."
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment